Opening book details…
Can I read FLT3 inhibitor KRN383 on xenografted human leukemic cells harboring FLT3-activating mutations on EtoBox?
FLT3 inhibitor KRN383 on xenografted human leukemic cells harboring FLT3-activating mutations by Francis J. Giles is a Medicine article available to read on EtoBox.
What is FLT3 inhibitor KRN383 on xenografted human leukemic cells harboring FLT3-activating mutations about?
Aberrant FLT3 function in leukemia blasts is associated with a poor prognosis. A number of FLT3 modulators are in development. FLT3 mutations may synergistize with other molecular abnormalities in myeloid transformation. Further insights into FLT3 biology are needed to optimally study the therapeutic role of FLT3 inhibitors.
Who reads FLT3 inhibitor KRN383 on xenografted human leukemic cells harboring FLT3-activating mutations?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Francis J. Giles
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0145-2126)
- Published
- 2006
- Language
- EN
- Field
- Medicine (Health Sciences)